Insuman Comb 50 Solostar

Insulin Human, the active ingredient in Insuman Comb 50 Solostar, is an insulin presented as a 50 IU/mL solution for injection for subcutaneous use. It treats type 1 and type 2 diabetes mellitus in patients requiring insulin therapy.

GNH USA supplies Insuman Comb 50 Solostar as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 50 Solostar provides insulin therapy for diabetes management and related insulin deficiency conditions.

- Type 1 diabetes mellitus: supplies basal and prandial insulin to achieve glycemic control. - Type 2 diabetes mellitus: used when oral agents are insufficient to meet target blood glucose levels. - Insulin deficiency states: replaces endogenous insulin to maintain normal glucose metabolism.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if meals are missed. - Injection site pain or erythema: mild discomfort at the injection site. - Lipodystrophy: localized thickening or thinning of subcutaneous tissue. - Weight gain: increase in body weight due to improved glucose utilization. - Edema: mild swelling of extremities. - Allergic skin reactions: rash or itching at the site.

Serious or Rare Side Effects: - Severe hypoglycemia leading to seizures or loss of consciousness. - Anaphylactic reaction: rapid onset of breathing difficulty, swelling, or hives. - Hypersensitivity with systemic symptoms such as fever or malaise. - Insulin antibody syndrome: formation of antibodies that alter insulin action. - Lipoatrophy: marked loss of subcutaneous fat at injection sites. - Severe allergic reactions: including angioedema.

Insuman Comb 50 Solostar requires careful monitoring and individualized dosing.

- Renal impairment: adjust dose and monitor glucose closely. - Hepatic dysfunction: consider reduced clearance and monitor for hypoglycemia. - Pregnancy: use only if benefits outweigh potential risks; category unknown. - Elderly patients: start with lower doses and titrate slowly. - Concomitant beta‑blockers: may mask hypoglycemia symptoms, requiring vigilant glucose checks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 50 Solostar can interact with several drug classes, affecting glucose control.

Major Interactions (Avoid): - Concurrent use of other insulin products: risk of additive hypoglycemia. - Meglitinides (e.g., repaglinide): increased hypoglycemia potential.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt hypoglycemia warning signs. - ACE inhibitors and ARBs: can potentiate insulin’s glucose‑lowering effect. - Thiazide diuretics: may raise blood glucose, requiring dose adjustment. - Alcohol: enhances insulin action and can precipitate hypoglycemia. - Oral contraceptives: may alter insulin requirements.